Can stem cell therapy improve lung function in COPD?

Yes. MSC therapy reduces pulmonary inflammation, promotes tissue repair in damaged airways, and may slow disease progression. Studies show improvements in FEV1, exercise capacity, and quality of life in COPD patients.

How is stem cell therapy administered for COPD?

COPD patients receive MSCs via IV infusion, which allows the cells to home to damaged lung tissue. The anti-inflammatory and regenerative properties of MSCs help restore pulmonary function.

COPD Stem Cell Therapy in Istanbul, Turkey

Stem cell therapy for COPD and chronic lung disease. MSC treatments improve lung function, reduce pulmonary inflammation, and help slow disease progression.

About Copd Stem Cell Therapy in Istanbul

Stem cell therapy for COPD (chronic obstructive pulmonary disease) at StemCell Longevita in Istanbul, Turkey offers a regenerative approach to improving lung function and quality of life. Our MSC treatments reduce pulmonary inflammation, promote airway tissue repair, and may slow the progressive lung damage that characterizes COPD and chronic lung disease.

How Stem Cell Therapy Works for This Condition

COPD involves chronic airway inflammation, mucus hypersecretion, and progressive destruction of lung tissue (emphysema). MSCs home to damaged lung tissue after IV infusion, where they reduce pulmonary inflammation by suppressing pro-inflammatory macrophages and cytokines, promote repair of damaged alveolar epithelium, reduce airway fibrosis, and improve pulmonary microvascular circulation. Studies in Chest and Respiratory Research show MSC therapy can improve FEV1, reduce exacerbation frequency, and enhance exercise capacity in COPD patients.

Who Is a Candidate?

Candidates include patients with moderate to severe COPD (GOLD stages II-IV), chronic bronchitis, emphysema, and those with declining lung function despite optimal inhaler therapy. Patients experiencing frequent exacerbations, exercise intolerance, or oxygen dependency may benefit significantly.

Treatment Process at StemCell Longevita

Treatment begins with review of your pulmonary function tests (spirometry), chest imaging, and current respiratory management. In Istanbul, you undergo comprehensive pulmonary assessment before IV infusion of MSCs. The cells naturally home to inflamed lung tissue after systemic delivery. Treatment takes 3-5 days including evaluation and monitoring.

Expected Results & Recovery

Patients typically report reduced breathlessness, improved exercise tolerance, fewer exacerbations, better oxygen saturation levels, reduced dependence on supplemental oxygen, improved sleep quality, and enhanced overall quality of life within 2-4 months. Spirometric improvements may be seen on follow-up pulmonary function testing.

Why Choose Turkey for Treatment?

Istanbul's modern respiratory medicine facilities and our specialized pulmonary stem cell protocols make Turkey an ideal destination for COPD patients seeking regenerative treatment at affordable prices — 60-80% less than equivalent care in the US or UK.

Cost of Treatment

COPD stem cell therapy from €6,950, including pulmonary assessment, MSC infusion, hotel accommodation, VIP transfers, and 12-month respiratory follow-up.

Part of Our Liver & Metabolic Conditions Treatment Cluster

Liver & Metabolic Conditions — Treatment Cluster

Pillar: stem cell therapy for liver disease in Istanbul

Research & guides: MSC therapy for diabetes management in Turkey | stem cell treatment for liver cirrhosis and fibrosis in Istanbul

Frequently Asked Questions About COPD Stem Cell Therapy

Can stem cell therapy improve lung function in COPD?: Yes. MSC therapy reduces pulmonary inflammation, promotes tissue repair in damaged airways, and may slow disease progression. Studies show improvements in FEV1, exercise capacity, and quality of life in COPD patients.
How is stem cell therapy administered for COPD?: COPD patients receive MSCs via IV infusion, which allows the cells to home to damaged lung tissue. The anti-inflammatory and regenerative properties of MSCs help restore pulmonary function.
What improvements can COPD patients expect?: Patients typically report reduced breathlessness, improved exercise tolerance, fewer exacerbations, better oxygen saturation levels, and enhanced quality of life within 2-4 months of treatment.